Leading the way to safer medication
 Crosscheck  Recommender

AIMOVIG

Found in: Austria Canada Cyprus Spain France Singapore United Kingdom United States

Active Ingredients

#
Chemical substance
Description
1
Erenumab

Erenumab is a human monoclonal antibody that binds to the calcitonin gene-related peptide (CGRP) receptor. CGRP is a neuropeptide that modulates nociceptive signalling and a vasodilator that has been associated with migraine pathophysiology. Inhibition of the effects of CGRP could theoretically attenuate compensatory vasodilation in ischaemic-related conditions.

ATC Classification

Code
Title
Category
N02CD01
Erenumab
N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CD Calcitonin gene-related peptide (CGRP) antagonists

Product Monographs

Monograph
Type
Country
AIMOVIG Solution for injection
MPI, EU: SmPC

Identifiers

Authority
Identifier(s)
FDA, National Drug Code (US)
Identifier(s): 55513-840, 55513-841, 55513-842, 55513-843
Health Products and Food Branch (CA)
Identifier(s): 02479613, 02487306
Health Sciences Authority (SG)
Identifier(s): 15543P, 15545P
Base de données publique des médicaments (FR)
Identifier(s): 63401330, 64453981
Centro de información online de medicamentos de la AEMPS (ES)
Identifier(s): 1181293001, 1181293004